Qunqi Hu

Qunqi Hu

Auto-generated profile, based on publicly available information

Qunqi Hu

Key Laboratory of Acupuncture and Neurology of Zhejiang Province, The Third Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People’s Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YMYi-Qi Ma
Yi-Qi Ma
QHQun-Qi Hu
Qun-Qi Hu
YKYu Rong Kang
Yu Rong Kang
LMLi-Qian Ma
Li-Qian Ma
SQSi-Ying Qu
Si-Ying Qu
XHXiao-Fen He
Xiao-Fen He
Diabetic neuropathic pain (DNP) is a common complication of diabetes. Streptozotocin (STZ)‐induced changes of protein in dorsal root ganglion (DRG) and spinal cord dorsal horn (SCDH) are critical for DNP genesis. However, which proteins change remains elusive. Here, the DNP model was established by a single intraperitoneal injection of STZ, accompanied by increased fasting blood glucose (FBG), decreased body weight (BW), and decreased paw withdrawal latency (PWL). Proteins change in L4‐L6 DRGs and SCDH of rats were detected. Western blot and immunofluorescence results showed that expression levels of phosphorylated protein kinase C (p‐PKC), transient receptor potential vanilloid‐1 (TRPV1), Substance P (SP) and calcitonin gene‐related peptide (CGRP) in the DRG and the SCDH of rats were increased after STZ injection. A preliminary study from our previous study showed that 2 Hz electroacupuncture (EA) effectively alleviates DNP. However, the analgesic mechanism of EA needs further elucidation. Here, EA at the bilateral Zusanli (ST36) and KunLun (BL60) acupoints was applied for one week, and to investigate the effect on DNP. EA reversed thermal hyperalgesia in DNP rats and downregulated the expression of p‐PKC, TRPV1, SP, and CGRP in DRG and SCDH.

1 December 2023 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
HWHanzhi Wang
Hanzhi Wang
SQSiying Qu
Siying Qu
TZTianshu Zhou
Tianshu Zhou
QHQunqi Hu
Qunqi Hu
XZXiaoxuan Zhao
Xiaoxuan Zhao
HZHong-li Zhao
Hong-li Zhao
Purpose: This bibliometric research aims to delineate global publication trends and emerging research interests in the use of acupuncture for breast cancer (BC)-related symptoms treatment over the past three decades. Furthermore, it identifies influential institutions, potential collaborative partners, and future research trends, thereby providing guidance for relevant, novel research directions. Methods: Scientific publications related to acupuncture for BC-related symptoms were gathered from the Web of Science Core Collection (WoSCC) from 1993 to 2023. Four software applications were principally used to analyze the resulting data: the “bibliometrix” package in the R environment (version 4.2.3), VOSviewer, CiteSpace6.1.R6, and the bibliometrics website. These applications were employed to evaluate different parameters. Results: A total of 621 papers on acupuncture in BC-related symptoms treatment were analyzed. The United States, China, and South Korea contributed the most, with Memorial Sloan Kettering Cancer Center, and Columbia University leading institutions. It is interesting to mention that Mao, Jun J. and Molassiotis, A. feature among the top 10 authors and co-cited authors. JAMA is the leading journal, with an ongoing focus on acupuncture’s effectiveness. Keywords show that the initial research focus was mainly on “vasomotor symptoms”, but in recent years there has been a gradual shift towards “pain”, “chemotherapy-induced peripheral neuropathy (CIPN)”, “electroacupuncture”, and “non-specific effects”. Conclusion: Acupuncture has demonstrated a unique value in the process of adjuvant treatment of BC-related symptoms, and has been shown to be effective in reducing pain, eliminating fatigue, and improving quality of life. The study of the mechanisms of acupuncture and the application of electroacupuncture are possible future research priorities in this field. This study offers a deep perspective on acupuncture for BC research, highlighting key points and future trends.

12 February 2022
Verified
Journal Article
Closed access
QHQun-Qi Hu
Qun-Qi Hu
YMYi-Qi Ma
Yi-Qi Ma
XFXue-Yu Fei
Xue-Yu Fei
LCLu-Hang Chen
Lu-Hang Chen
YKYu-Rong Kang
Yu-Rong Kang
XHXiao-Fen He
Xiao-Fen He

1 May 2026 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
QHQunqi Hu
Qunqi Hu
NCNisang Chen
Nisang Chen
Letter for the article Efficacy of Cognitive Behavioral Therapy Combined with Exercise in Patients with Chronic Pain: A Systematic Review and Meta-Analysis

1 September 2026 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
HCHengyu Chi
Hengyu Chi
QHQunqi Hu
Qunqi Hu
JLJingqi Liang
Jingqi Liang
JZJingjing Zhang
Jingjing Zhang
SQSiying Qu
Siying Qu
YZYinhang Zhong
Yinhang Zhong
Purpose: Perimenopause represents a critical neuroendocrine transition stage in the lives of women, characterized by metabolic disorders and physiological vulnerability, which also commonly manifests as depression and cognitive impairment. This study explores associations between the triglyceride-glucose-frailty index (TyGFI) and depression/cognitive impairment in perimenopausal women. Methods: Data were obtained from the 2015 China Health and Retirement Longitudinal Study (CHARLS) and 2,596 perimenopausal women were included. Logistic regression models were used to evaluate the association between TyGFI and depression/cognitive impairment. Restricted cubic spline (RCS) curves were plotted to visualize the dose–response relationship. Subgroup analyses and receiver operating characteristic (ROC) curves were used to assess interaction effects and evaluate the discriminatory ability of TyGFI. The results were expressed as odds ratios (OR) with 95% confidence intervals (CI). Results: Perimenopausal women with higher TyGFI levels exhibited a greater tendency towards depression and cognitive impairment, older age, higher blood pressure, and poorer self-reported health. In the fully adjusted model, each one-point increase in TyGFI was associated with elevated risk of depression (OR = 3.70, 95% CI: 3.18– 4.32) and cognitive impairment (OR = 1.51, 95% CI: 1.34– 1.71). RCS curves confirmed non-linear, positive associations and clear dose–response trends. Subgroup analysis revealed that the associations remained largely robust across most subgroups. ROC analysis demonstrated moderate-to-good discriminatory ability, with area under the curve (AUC) of 0.786 for depression and 0.634 for cognitive impairment. Conclusion: The TyGFI was concurrently correlated with depression and cognitive impairment in Chinese perimenopausal women, which may serve as a potential indicator for clinical risk screening.